Literature DB >> 17726338

EMEA guidelines on biosimilars and their clinical implications.

Jerome Rossert1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17726338     DOI： 10.1159/000107276

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN： 1420-4096            Impact factor:   2.687


× No keyword cloud information.
  2 in total

1.  The economic pressures for biosimilar drug use in cancer medicine.

Authors:  Paul Cornes
Journal:  Target Oncol       Date:  2012-01-17       Impact factor: 4.493

Review 2.  Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility.

Authors:  Mary Lynn Davis-Ajami; Jun Wu; Katherine Downton; Emilie Ludeman; Virginia Noxon
Journal:  Biologics       Date:  2014-04-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.